Maternal minimal and maximal concentrations (Cmin and Cmax) and AUCs derived from women's individual pharmacokinetic estimates, after a 400-mg FTC dose was administered to each of the HIV-infected pregnant women (n = 38) enrolled in the TEmAA ANRS 12109 trial, step 1, compared to median values for other adults after a 200-mg FTC dose at steady state